Cargando…
Sweden’s first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals
BACKGROUND: Opioid overdoses are a growing concern, particularly among people who inject drugs. Sweden, with a comparatively high proportion of drug-related mortality, introduced its first Take-Home Naloxone (THN) program in 2018, at the Stockholm needle and syringe program (NSP). In this study we c...
Autores principales: | Holmén, Elin, Warnqvist, Anna, Kåberg, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121425/ https://www.ncbi.nlm.nih.gov/pubmed/37087485 http://dx.doi.org/10.1186/s13011-023-00533-2 |
Ejemplares similares
-
Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program
por: Katzman, Joanna G., et al.
Publicado: (2020) -
Guidance on take-home naloxone distribution and use by community overdose responders in Canada
por: Ferguson, Max, et al.
Publicado: (2023) -
Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
por: Straus, Michele M, et al.
Publicado: (2013) -
A rapid assessment of take-home naloxone provision during COVID-19 in Europe
por: McDonald, Rebecca, et al.
Publicado: (2022) -
Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review
por: Moustaqim-Barrette, Amina, et al.
Publicado: (2021)